Skip to main content
Erschienen in: Pediatric Nephrology 7/2013

01.07.2013 | Editorial Commentary

Cystatin C adaptation in the first month of life

verfasst von: Guido Filler, Nathalie Lepage

Erschienen in: Pediatric Nephrology | Ausgabe 7/2013

Einloggen, um Zugang zu erhalten

Abstract

Je-Hyan Lee et al. have published a study on cystatin C concentrations in the first 30 days of life in 127 pre-term and 119 term neonates in this edition of Pediatric Nephrology, thereby closing a knowledge gap of detailed cystatin C concentrations beyond 72 h of life by day of life and by post-conceptional age. While the study objective has merit and a large number of measurements were included, there are some methodological limitations that bring the validity of the data into question as pure reference intervals for children up to 1 month of age, mostly because of the inclusion of patients that potentially could have an impaired glomerular filtration rate (GFR), for instance due to exposure to nephrotoxic drugs. We discuss the strengths and weaknesses of the study and outline an approach to definitely close this knowledge gap. We call for a worldwide collaboration to use Box–Cox transformations similar to the methodology used with growth charts to calculate age-independent z-scores and percentiles of neonatal and infant markers of GFR. This could also lead to better definitions of acute kidney injury in infants if GFR markers cross the percentiles based on post-conceptional or chronological age.
Literatur
1.
Zurück zum Zitat Strauss J, Daniel SS, James LS (1981) Postnatal adjustment in renal function. Pediatrics 68:802–808PubMed Strauss J, Daniel SS, James LS (1981) Postnatal adjustment in renal function. Pediatrics 68:802–808PubMed
2.
Zurück zum Zitat Chevalier RL (1982) Functional adaptation to reduced renal mass in early development. Am J Physiol 242:F190–196PubMed Chevalier RL (1982) Functional adaptation to reduced renal mass in early development. Am J Physiol 242:F190–196PubMed
3.
Zurück zum Zitat Filler GM (2011) The challenges of assessing acute kidney injury in infants. Kidney Int 80:567–568PubMedCrossRef Filler GM (2011) The challenges of assessing acute kidney injury in infants. Kidney Int 80:567–568PubMedCrossRef
4.
Zurück zum Zitat Filler G, Browne R, Seikaly MG (2003) Glomerular filtration rate as a putative ‘surrogate end-point’ for renal transplant clinical trials in children. Pediatr Transplant 7:18–24PubMedCrossRef Filler G, Browne R, Seikaly MG (2003) Glomerular filtration rate as a putative ‘surrogate end-point’ for renal transplant clinical trials in children. Pediatr Transplant 7:18–24PubMedCrossRef
5.
Zurück zum Zitat Filler G, Grimmer J, Huang SHS, Bariciak E (2012) Cystatin C for the assessment of GFR in neonates with congenital renal anomalies. Nephrol Dial Transplant 27:3382–3384PubMedCrossRef Filler G, Grimmer J, Huang SHS, Bariciak E (2012) Cystatin C for the assessment of GFR in neonates with congenital renal anomalies. Nephrol Dial Transplant 27:3382–3384PubMedCrossRef
6.
Zurück zum Zitat Choi YJ, Baranowska-Daca E, Nguyen V, Koji T, Ballantyne CM, Sheikh-Hamad D, Suki WN, Truong LD (2000) Mechanism of chronic obstructive uropathy: increased expression of apoptosis-promoting molecules. Kidney Int 58:1481–1491PubMedCrossRef Choi YJ, Baranowska-Daca E, Nguyen V, Koji T, Ballantyne CM, Sheikh-Hamad D, Suki WN, Truong LD (2000) Mechanism of chronic obstructive uropathy: increased expression of apoptosis-promoting molecules. Kidney Int 58:1481–1491PubMedCrossRef
7.
Zurück zum Zitat Popper H, Mandel E (1937) Filiations- und Reabsorptionsleitung in der Nierenpathologie. Ergeb Inn Med Kinderheilkd 53:685–694CrossRef Popper H, Mandel E (1937) Filiations- und Reabsorptionsleitung in der Nierenpathologie. Ergeb Inn Med Kinderheilkd 53:685–694CrossRef
8.
9.
Zurück zum Zitat Filler G, Bokenkamp A, Hofmann W, Le Bricon T, Martinez-Bru C, Grubb A (2005) Cystatin C as a marker of GFR—history, indications, and future research. Clin Biochem 38:1–8PubMedCrossRef Filler G, Bokenkamp A, Hofmann W, Le Bricon T, Martinez-Bru C, Grubb A (2005) Cystatin C as a marker of GFR—history, indications, and future research. Clin Biochem 38:1–8PubMedCrossRef
10.
Zurück zum Zitat Dharnidharka VR, Kwon C, Stevens G (2002) Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 40:221–226PubMedCrossRef Dharnidharka VR, Kwon C, Stevens G (2002) Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 40:221–226PubMedCrossRef
11.
Zurück zum Zitat Pham-Huy A, Leonard M, Lepage N, Halton J, Filler G (2003) Measuring glomerular filtration rate with cystatin C and [beta]-trace protein in children with spina bifida. J Urol 169:2312–2315PubMedCrossRef Pham-Huy A, Leonard M, Lepage N, Halton J, Filler G (2003) Measuring glomerular filtration rate with cystatin C and [beta]-trace protein in children with spina bifida. J Urol 169:2312–2315PubMedCrossRef
12.
Zurück zum Zitat Sharma AP, Kathiravelu A, Nadarajah R, Yasin A, Filler G (2009) Body mass does not have a clinically relevant effect on cystatin C eGFR in children. Nephrol Dial Transplant 24:470–474PubMedCrossRef Sharma AP, Kathiravelu A, Nadarajah R, Yasin A, Filler G (2009) Body mass does not have a clinically relevant effect on cystatin C eGFR in children. Nephrol Dial Transplant 24:470–474PubMedCrossRef
13.
Zurück zum Zitat Schwartz GJ, Schneider MF, Maier PS, Moxey-Mims M, Dharnidharka VR, Warady BA, Furth SL, Munoz A (2012) Improved equations estimating GFR in children with chronic kidney disease using an immunonephelometric determination of cystatin C. Kidney Int 82:445–453PubMedCrossRef Schwartz GJ, Schneider MF, Maier PS, Moxey-Mims M, Dharnidharka VR, Warady BA, Furth SL, Munoz A (2012) Improved equations estimating GFR in children with chronic kidney disease using an immunonephelometric determination of cystatin C. Kidney Int 82:445–453PubMedCrossRef
14.
Zurück zum Zitat Plebani M, Mussap M, Bertelli L, Moggi G, Ruzzante N, Fanos V, Cataldi L (1997) Determination of blood cystatin C in pregnant women during labor and in their newborns. Pediatr Med Chir 19:325–329PubMed Plebani M, Mussap M, Bertelli L, Moggi G, Ruzzante N, Fanos V, Cataldi L (1997) Determination of blood cystatin C in pregnant women during labor and in their newborns. Pediatr Med Chir 19:325–329PubMed
15.
Zurück zum Zitat Cataldi L, Mussap M, Bertelli L, Ruzzante N, Fanos V, Plebani M (1999) Cystatin C in healthy women at term pregnancy and in their infant newborns: relationship between maternal and neonatal serum levels and reference values. Am J Perinatol 16:287–295PubMedCrossRef Cataldi L, Mussap M, Bertelli L, Ruzzante N, Fanos V, Plebani M (1999) Cystatin C in healthy women at term pregnancy and in their infant newborns: relationship between maternal and neonatal serum levels and reference values. Am J Perinatol 16:287–295PubMedCrossRef
16.
Zurück zum Zitat Bokenkamp A, Dieterich C, Dressler F, Muhlhaus K, Gembruch U, Bald R, Kirschstein M (2001) Fetal serum concentrations of cystatin C and beta2-microglobulin as predictors of postnatal kidney function. Am J Obstet Gynecol 185:468–475PubMedCrossRef Bokenkamp A, Dieterich C, Dressler F, Muhlhaus K, Gembruch U, Bald R, Kirschstein M (2001) Fetal serum concentrations of cystatin C and beta2-microglobulin as predictors of postnatal kidney function. Am J Obstet Gynecol 185:468–475PubMedCrossRef
17.
Zurück zum Zitat Bariciak E, Abeeryasin HJ, Walker M, Lepage N, Filler G (2011) Preliminary reference intervals for cystatin C and beta-trace protein in preterm and term neonates. Clin Biochem 44:1156–1159PubMedCrossRef Bariciak E, Abeeryasin HJ, Walker M, Lepage N, Filler G (2011) Preliminary reference intervals for cystatin C and beta-trace protein in preterm and term neonates. Clin Biochem 44:1156–1159PubMedCrossRef
18.
Zurück zum Zitat Harmoinen A, Ylinen E, Ala-Houhala M, Janas M, Kaila M, Kouri T (2000) Reference intervals for cystatin C in pre- and full-term infants and children. Pediatr Nephrol 15:105–108PubMedCrossRef Harmoinen A, Ylinen E, Ala-Houhala M, Janas M, Kaila M, Kouri T (2000) Reference intervals for cystatin C in pre- and full-term infants and children. Pediatr Nephrol 15:105–108PubMedCrossRef
19.
Zurück zum Zitat Bokenkamp A, Domanetzki M, Zinck R, Schumann G, Brodehl J (1998) Reference values for cystatin C serum concentrations in children. Pediatr Nephrol 12:125–129PubMedCrossRef Bokenkamp A, Domanetzki M, Zinck R, Schumann G, Brodehl J (1998) Reference values for cystatin C serum concentrations in children. Pediatr Nephrol 12:125–129PubMedCrossRef
20.
Zurück zum Zitat Lee J, Hahn W, Ahn J, Chang J, Bae C (2013) Serum Cystatin C of 30 postnatal days is dependent on the postconceptional age in neonates. Pediatr Nephrol. doi:10.1007/s00467-013-2429-4 Lee J, Hahn W, Ahn J, Chang J, Bae C (2013) Serum Cystatin C of 30 postnatal days is dependent on the postconceptional age in neonates. Pediatr Nephrol. doi:10.​1007/​s00467-013-2429-4
21.
Zurück zum Zitat Rhodin MM, Anderson BJ, Peters AM, Coulthard MG, Wilkins B, Cole M, Chatelut E, Grubb A, Veal GJ, Keir MJ, Holford NH (2009) Human renal function maturation: a quantitative description using weight and postmenstrual age. Pediatr Nephrol 24:67–76PubMedCrossRef Rhodin MM, Anderson BJ, Peters AM, Coulthard MG, Wilkins B, Cole M, Chatelut E, Grubb A, Veal GJ, Keir MJ, Holford NH (2009) Human renal function maturation: a quantitative description using weight and postmenstrual age. Pediatr Nephrol 24:67–76PubMedCrossRef
22.
Zurück zum Zitat Filler G, Witt I, Priem F, Ehrich JH, Jung K (1997) Are cystatin C and beta 2-microglobulin better markers than serum creatinine for prediction of a normal glomerular filtration rate in pediatric subjects? Clin Chem 43:1077–1078PubMed Filler G, Witt I, Priem F, Ehrich JH, Jung K (1997) Are cystatin C and beta 2-microglobulin better markers than serum creatinine for prediction of a normal glomerular filtration rate in pediatric subjects? Clin Chem 43:1077–1078PubMed
23.
Zurück zum Zitat Burritt MF, Slockbower JM, Forsman RW, Offord KP, Bergstralh EJ, Smithson WA (1990) Pediatric reference intervals for 19 biologic variables in healthy children. Mayo Clin Proc 65:329–336PubMedCrossRef Burritt MF, Slockbower JM, Forsman RW, Offord KP, Bergstralh EJ, Smithson WA (1990) Pediatric reference intervals for 19 biologic variables in healthy children. Mayo Clin Proc 65:329–336PubMedCrossRef
24.
Zurück zum Zitat Filler G, Lepage N (2003) Should the Schwartz formula for estimation of GFR be replaced by cystatin C formula? Pediatr Nephrol 18:981–985PubMedCrossRef Filler G, Lepage N (2003) Should the Schwartz formula for estimation of GFR be replaced by cystatin C formula? Pediatr Nephrol 18:981–985PubMedCrossRef
25.
Zurück zum Zitat Yasin A, Benidir A, Filler G (2012) Are Canadian pediatric nephrology patients really overweight? Clin Nephrol 78:359–364PubMed Yasin A, Benidir A, Filler G (2012) Are Canadian pediatric nephrology patients really overweight? Clin Nephrol 78:359–364PubMed
26.
Zurück zum Zitat Filler G, Yasin A, Kesarwani P, Garg AX, Lindsay R, Sharma AP (2011) Big mother or small baby: which predicts hypertension? J Clin Hypertens 13:35–41CrossRef Filler G, Yasin A, Kesarwani P, Garg AX, Lindsay R, Sharma AP (2011) Big mother or small baby: which predicts hypertension? J Clin Hypertens 13:35–41CrossRef
Metadaten
Titel
Cystatin C adaptation in the first month of life
verfasst von
Guido Filler
Nathalie Lepage
Publikationsdatum
01.07.2013
Verlag
Springer-Verlag
Erschienen in
Pediatric Nephrology / Ausgabe 7/2013
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-013-2428-5

Weitere Artikel der Ausgabe 7/2013

Pediatric Nephrology 7/2013 Zur Ausgabe

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.